ZKTeco BioTime Path Traversal Vulnerability
n/a — n/a
A path traversal vulnerability in the iclock API of ZKTeco BioTime v8.5.5 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload. This vulnerability was fixed in version 9.0.120240617.19506 of ZKBioTime.
7.5
84.9%
Vector breakdown
- Attack vector
- Network
- Attack complexity
- Low
- Privileges required
- None
- User interaction
- None
- Scope
- Unchanged
- Confidentiality
- High
- Integrity
- None
- Availability
- None
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- Published
- Aug 3, 2023
- Modified
- Jul 9, 2026
- Added to KEV
- May 19, 2025
- Federal patch due
- Jun 9, 2025
CISA required action
Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.
Weakness classification
Proof-of-concept & exploitation references
Weaponization
Public repositories whose name or description references CVE-2023-38950, found via a live GitHub search at request time. These are community-sourced signals, not a verified working exploit - cross-check each one before relying on it, and treat higher star counts and recent activity as (weak) corroboration, not proof.
No public GitHub repositories referencing CVE-2023-38950 were found at last check. Absence here is not proof no exploit exists - see the references below for vendor advisories and write-ups.
References
Frequently asked questions
What is CVE-2023-38950?
A path traversal vulnerability in the iclock API of ZKTeco BioTime v8.5.5 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload. This vulnerability was fixed in version 9.0.120240617.19506 of ZKBioTime.
How severe is CVE-2023-38950?
CVE-2023-38950 has a CVSS base score of 7.5 out of 10 (CVSS 3.1).
Is CVE-2023-38950 actively exploited in the wild?
Yes. CVE-2023-38950 is listed in the CISA Known Exploited Vulnerabilities (KEV) catalog, added May 19, 2025, meaning CISA has confirmed evidence of active exploitation.
What is the EPSS score for CVE-2023-38950?
84.9% - meaning FIRST.org's EPSS model estimates a 84.9% probability this vulnerability will be exploited in the wild within 30 days (100% percentile among all scored CVEs).
Is there exploit tooling available for CVE-2023-38950?
Yes - a public Nuclei template referencing CVE-2023-38950 exist in public repositories we checked.
What type of vulnerability is CVE-2023-38950?
CVE-2023-38950 is classified under CWE-22 (CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')).
Cross-checked against
Impactr finds and proves whether CVE-2023-38950 - or flaws like it - are actually reachable in your own web apps and APIs, with a reproducible exploit as evidence.
Join the waitlist